Home Compare EW vs IPN.PA
Stock Comparison · Single-driver result

Edwards Lifesciences vs Ipsen: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Edwards Lifesciences carrying a narrow edge on growth. Ipsen still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (EW: Russell 1000, IPN.PA: STOXX 600).

Updated 2026-05-17

Growth is the clearest driver, while stability keeps the result from looking one-way.

Trajectory Similarity
0.72
Similar
Peer-set rank: #2
within Edwards Lifesciences Corporation's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

Most of the shared profile comes through revenue stability and capital structure.

Similarity drivers
revenue stabilitycapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EW
Edwards Lifesciences Corporation
49
Peer-Score
Signal qualitylow
Peer basis: Russell 1000
vs
IPN.PA
Ipsen S.A.
44
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: EW vs IPN.PA Profitability 38 28 Stability 50 76 Valuation 43 44 Growth 71 37 EW IPN.PA
Gap Ranking
#1 Growth +34
#2 Stability +26
#3 Profitability +10
#4 Valuation +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EW and IPN.PA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EWIPN.PA Relative valuation Structural strength

The setup remains mixed because the stronger profile and the more supportive price setup do not sit on the same side.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where EW and IPN.PA each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY EW Neutral · above norm 0th 50th 100th 52 pct gap IPN.PA Elevated · above norm 0th 50th 100th 46th 98th
Today EW sits in the lower-middle of its own 5-year history (46th percentile), while IPN.PA sits higher in its own history (98th). Within each stock's own 5-year context, EW is at a historically more favourable entry position than IPN.PA. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Growth
On growth, Edwards Lifesciences Corporation ranks near the top of the group; Ipsen S.A. sits in the weaker half.
Stability
On stability, the edge still sits with Ipsen S.A., even though both profiles look solid.
Growth — Dominant Gap
EW
71
IPN.PA
37
Gap+34in favour of EW

The current lead is backed by a stronger multi-year growth trajectory.

What keeps the gap from being one-sided

There is still a strong counterforce in stability, so the lead stays clear without becoming a sweep.

What this means for the comparison

The page question resolves through growth, but stability and current pricing still keep the broader comparison from reading as fully aligned.

Explore full peer positioning in AssetNext

Break down the EW vs IPN.PA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how EW and IPN.PA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.